GEN1057
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GEN1057, covering 2026-04-13 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Trial to Assess the Safety and Antitumor Activity of GEN1057 in Malignant Solid Tumors [Phase 1]